SCHEMBL25207342

SCHEMBL25207342

CCCCCCCCCC(=O)NC(=O)c1ccc(O)c(OC)c1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.62
CYP3A4 P08684 3/20 0.62
CYP2D6 P10635 2/20 0.62
HPGD P15428 2/20 0.62
CYP2C9 P11712 2/20 0.62
CYP2C19 P33261 2/20 0.62
ALDH1A1 P00352 1/20 0.62
ALOX15 P16050 1/20 0.62
BLM P54132 1/20 0.62
PMP22 Q01453 1/20 0.62
TRPV1 Q8NER1 5/20 0.59
SMPD1 P17405 1/20 0.56
MEN1 O00255 1/20 0.56
TP53 P04637 1/20 0.56
MAPT P10636 1/20 0.56
MTOR P42345 1/20 0.56
KMT2A Q03164 1/20 0.56
CYP2C8 P10632 1/20 0.55
CYP2B6 P20813 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8656439 1.00 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6HPGDCYP2C9
SCHEMBL31313272 1.00 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6HPGDCYP2C9
SCHEMBL31313342 1.00 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6HPGDCYP2C9
SCHEMBL29565211 1.00 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6HPGDCYP2C9
SCHEMBL10651740 1.00 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6HPGDCYP2C9
SCHEMBL25235601 1.00 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6HPGDCYP2C9
SCHEMBL2683268 1.00 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6HPGDCYP2C9
SCHEMBL28522760 0.99 CYP1A2 (0.61) CYP1A2CYP3A4CYP2D6HPGDCYP2C9
SCHEMBL28513121 0.99 CYP1A2 (0.61) CYP1A2CYP3A4CYP2D6HPGDCYP2C9
SCHEMBL3191884 0.93 TRPV1 (0.67) CYP1A2CYP3A4CYP2D6HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230310351-A1 REGIMEN FOR REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCH GRUENENTHAL GMBH (DE) 2023-10-05 US disclosed
US-20230157977-A1 REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCH FOR TREATING INITIAL NON-RESPONDERS GRUENENTHAL GMBH (DE) 2023-05-25 US disclosed
CN-111647537-B Salt-tolerant capsaicin degrading bacteria, application and kitchen waste treatment method 浙江工业大学 2022-04-26 CN disclosed
CN-111647536-B High-temperature-resistant capsaicin degrading bacteria, application and kitchen waste treatment method 浙江工业大学 2022-03-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230157977-A1 REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCH FOR TREATING INITIAL NON-RESPONDERS TRPV1, NTRK1, GAP43 CYP1A2 4549/4885CYP3A4 4603/4885CYP2D6 4123/4885
US-20230310351-A1 REGIMEN FOR REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCH TRPV1, PRPH, GAP43 CYP1A2 3477/4885CYP3A4 4089/4885CYP2D6 3177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.